Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-481707
Filing Date
2016-02-26
Accepted
2016-02-26 15:31:55
Documents
84
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d118305d10k.htm 10-K 1374985
2 EX-21.1 d118305dex211.htm EX-21.1 1766
3 EX-23.1 d118305dex231.htm EX-23.1 2150
4 EX-31.1 d118305dex311.htm EX-31.1 7449
5 EX-31.2 d118305dex312.htm EX-31.2 7263
6 EX-32.1 d118305dex321.htm EX-32.1 7123
13 GRAPHIC g118305g35r67.jpg GRAPHIC 84597
  Complete submission text file 0001193125-16-481707.txt   6864544

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT orex-20151231.xml EX-101.INS 1213100
8 XBRL TAXONOMY EXTENSION SCHEMA orex-20151231.xsd EX-101.SCH 68777
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20151231_cal.xml EX-101.CAL 89904
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orex-20151231_def.xml EX-101.DEF 420441
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20151231_lab.xml EX-101.LAB 596573
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20151231_pre.xml EX-101.PRE 487025
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33415 | Film No.: 161461173
SIC: 2834 Pharmaceutical Preparations